Seattle Genetics, Inc. (SGEN) Follows the Science, Taking on Rare Lymphoma No. 3
5/23/2012 8:32:37 AM
Sometimes when a drug hits the market, it can take on a life of its own. Researchers start using their imaginations—and their own grant money—to pursue applications the drugmaker itself might never have envisioned. And sometimes, those researchers make important new discoveries, which can provide the company with a running start on a potentially lucrative opportunity. One of those stories is happening now at Seattle Genetics.
comments powered by